Mednet Logo

When do you stop dantrolene in a patient with neuroleptic malignant syndrome?

1 Answer
Mednet Member
Mednet MemberInvited Expert
Neurology · Baylor College of Medicine
Answered on

Dantrolene is typically used to treat severe NMS, although the data supporting its use is mixed. The biggest risk with the therapy is hepatotoxicity. It is reasonable to discontinue dantrolene once the hyperthermia and severe muscle rigidity have resolved, or earlier if there is concern for liver in...

Join for free or sign in to see the full answer